Tech Company Financing Transactions
4G Clinical Funding Round
Goldman Sachs and private investors joined a $230 million venture round for 4G Clinical. This venture round closed on 7/1/2021.
Transaction Overview
Company Name
Announced On
7/1/2021
Transaction Type
Venture Equity
Amount
$230,000,000
Round
Undisclosed
Investors
Goldman Sachs (Lead Investor)
Proceeds Purpose
The company intends to use the funds for global expansion.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
370 Washington St.
Wellesley, MA 02481
USA
Wellesley, MA 02481
USA
Phone
Website
Email Address
Overview
We are RTSM pioneers, engineers and marketing experts determined to make a difference in the inefficiencies in clinical trials. There is so much work to be done to bring crucial medicines to those who need them, faster.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Kelleher
Chief Technical Officer
Ed Tourtellotte
VP - Bus. Development
Robert Campanella
VP - Client Services
Kathleen Greenough
VP - Client Services
Philip Woodson
VP - Customer Service
Teresa Goodnough
VP - Engineering
Simon West-Bulford
VP - Marketing
Amy Ripston
VP - Regulatory Affairs
Laura Araujo
Browse more venture capital transactions:
Prev: 7/1/2021: dbt Labs venture capital transaction
Next: 7/1/2021: Versa Networks venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs